Home/Filings/4/0000899243-21-010982
4//SEC Filing

Murphy Keith 4

Accession 0000899243-21-010982

CIK 0001497253other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 4:46 PM ET

Size

12.1 KB

Accession

0000899243-21-010982

Insider Transaction Report

Form 4
Period: 2021-03-08
Murphy Keith
DirectorChairman, CEO and President
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-03-08+60,00060,000 total
    Exercise: $10.27Exp: 2031-03-08Common Stock (60,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-03-08+45,00045,000 total
    Exercise: $10.27Exp: 2031-03-08Common Stock (45,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-03-08+60,00060,000 total
    Exercise: $10.27Exp: 2031-03-08Common Stock (60,000 underlying)
  • Award

    Common Stock

    2021-03-08+20,00066,320 total
Footnotes (4)
  • [F1]The reported securities are represented by restricted stock units, 25% of which shall vest on March 8, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
  • [F2]25% of the option shares vest and become exercisable on March 8, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
  • [F3]The option becomes exercisable, if at all, if the 45-day moving average closing price of Organovo Holdings, Inc.'s common stock on The Nasdaq Stock Market LLC exceeds $20.00 per share.
  • [F4]The option becomes exercisable, if at all, if the 45-day moving average closing price of Organovo Holdings, Inc.'s common stock on The Nasdaq Stock Market LLC exceeds $25.00 per share.

Issuer

ORGANOVO HOLDINGS, INC.

CIK 0001497253

Entity typeother

Related Parties

1
  • filerCIK 0001536583

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:46 PM ET
Size
12.1 KB